CN118984938A - 对活性型食欲素a进行定量的方法 - Google Patents

对活性型食欲素a进行定量的方法 Download PDF

Info

Publication number
CN118984938A
CN118984938A CN202380026755.6A CN202380026755A CN118984938A CN 118984938 A CN118984938 A CN 118984938A CN 202380026755 A CN202380026755 A CN 202380026755A CN 118984938 A CN118984938 A CN 118984938A
Authority
CN
China
Prior art keywords
orexin
disease
peptide
active
cerebrospinal fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380026755.6A
Other languages
English (en)
Chinese (zh)
Inventor
屈江勘太
田原和浩
汤本英美子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanitary Material R&d Management Co ltd
Original Assignee
Sanitary Material R&d Management Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanitary Material R&d Management Co ltd filed Critical Sanitary Material R&d Management Co ltd
Publication of CN118984938A publication Critical patent/CN118984938A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
CN202380026755.6A 2022-04-11 2023-04-10 对活性型食欲素a进行定量的方法 Pending CN118984938A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022065117 2022-04-11
JP2022-065117 2022-04-11
PCT/JP2023/014583 WO2023199893A1 (ja) 2022-04-11 2023-04-10 活性型オレキシンａを定量する方法

Publications (1)

Publication Number Publication Date
CN118984938A true CN118984938A (zh) 2024-11-19

Family

ID=88329773

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380026755.6A Pending CN118984938A (zh) 2022-04-11 2023-04-10 对活性型食欲素a进行定量的方法

Country Status (5)

Country Link
US (1) US20250189543A1 (https=)
EP (1) EP4478051A4 (https=)
JP (1) JPWO2023199893A1 (https=)
CN (1) CN118984938A (https=)
WO (1) WO2023199893A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025137359A1 (en) * 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025183053A1 (ja) * 2024-02-29 2025-09-04 株式会社島津製作所 生体液中のタウタンパク質の翻訳後修飾および／または断片化の質量分析法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000516456A (ja) * 1996-08-02 2000-12-12 ザ・スクリプス・リサーチ・インステイチユート 視床下部特異的ポリペプチド
EP1190089A4 (en) * 1999-06-25 2002-10-16 Smithkline Beecham Corp LIG 72A TREATMENT PROCESS AND VARIANTS THEREOF
WO2003092581A2 (en) * 2001-07-16 2003-11-13 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2018078018A2 (en) * 2016-10-27 2018-05-03 Glostrup Hospital Detection of hypocretin-1 and -2

Also Published As

Publication number Publication date
EP4478051A4 (en) 2026-01-21
WO2023199893A1 (ja) 2023-10-19
EP4478051A1 (en) 2024-12-18
US20250189543A1 (en) 2025-06-12
JPWO2023199893A1 (https=) 2023-10-19

Similar Documents

Publication Publication Date Title
CN106574930B (zh) 评价脑内的淀粉样蛋白β肽蓄积状态的替代性生物标记物和其分析方法
US11726099B2 (en) Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
CN118984938A (zh) 对活性型食欲素a进行定量的方法
KR101559101B1 (ko) 혈액유래 암 진단용 펩티드 마커 및 이를 이용한 암 진단방법
JP2016531546A (ja) 免疫グロブリン分子試料を分析する方法
US11630111B2 (en) Method for quantifying anti-TNF antibodies
EP2653476B1 (en) Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
JP2025098086A (ja) 血液試料を検体とするタウタンパク質検出方法
Chen et al. Sequential immunoaffinity-LC/MS assay for quantitation of a therapeutic protein in monkey plasma
JP6445861B2 (ja) オキシトシン検出のためのサンプルの前処理方法
CN111505315B (zh) 一种蛋白组合式标志物在制备儿童哮喘诊断试剂中的应用
US20190241607A1 (en) Compositions and methods for detection of beta n methylamino l alanine in cu zn superoxide dismutase 1
CN108026522B (zh) 特异性纯化的抗普莱晒谱星抗体
WO2020193500A1 (en) Use of a ps396 assay to diagnose tauophaties
CN114026109A (zh) β淀粉样蛋白的单克隆抗体、和使用该抗体的β淀粉样蛋白相关肽的测定方法
EP3371602B1 (en) A method for quantifying anti-tnf antibodies
Cocchiara et al. Purification of Par j I, a major allergen from Parietaria judaica pollen
WO2019012667A1 (ja) 認知機能障害疾患のバイオマーカー及び該バイオマーカーを用いる認知機能障害疾患の検出方法
EP2491402B1 (en) Blood coagulation status measurement in saliva
CN118376795B (zh) 尿液中n-糖基化蛋白组合作为靶标在早期诊断阿尔茨海默病中的应用
JP2025137899A (ja) シヌクレイノパチーを判定するための方法
CN119350504A (zh) 一种蛋白质半胱氨酸羧乙基化修饰检测的方法
WO2024047185A1 (en) Mass spectroscopy assay for detecting o-beta-linked n-acetylglucosaminylated tau peptides
JP2014181967A (ja) 中枢神経ループス（ｎｐｓｌｅ）診断用バイオマーカー
CN119643879A (zh) 脱髓鞘型吉兰-巴雷综合征相关抗Gelsolin3抗体的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination